Modeling pathogen and host: In vitro, in vivo and in silico models of latent Mycobacterium tuberculosis infection

Drug Discovery Today: Disease Models

Volumn 2, Issue 2, 2005, Pages 149-154

  Lin, P Ling ^a,b   Kirschner, Denise ^c   Flynn, Joanne L ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; INTERFERON; INTERLEUKIN 10; REACTIVE NITROGEN SPECIES; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL METABOLISM; CHRONIC DISEASE; COMPUTER MODEL; COST BENEFIT ANALYSIS; DISEASE MODEL; GENOMICS; HOST PATHOGEN INTERACTION; HYPOXIA; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL MODEL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEOMICS; TUBERCULOSIS;

EID: 21844457659     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2005.05.019     Document Type: Review

References (30)

1. L.G. Wayne Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions Am. Rev. Respir. Dis. 114 1976 807-811
2. J.D. McKinney et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase Nature 406 2000 735-738
3. H.I. Boshoff and C.E. Barry III Tuberculosis - metabolism and respiration in the absence of growth Nat. Rev. Microbiol. 3 2005 70-80
4. D.R. Sherman et al. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin Proc. Natl. Acad. Sci. USA 98 2001 7534-7539
5. L.G. Wayne and L.G. Hayes An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence Infect. Immun. 64 1996 2062-2069
6. J.L. Flynn et al. Animal models of tuberculosis. In Tuberculosis and the tubercle bacillus (S.T. Cole, ed) 2005 ASM Press 547-560
7. E.J. Munoz-Elias and J.D. McKinney Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence Nat. Med. 2005
8. R.J. Rees and P.D. Hart Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts Br. J. Exp. Pathol. 42 1961 83-88
9. J. Chan et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis Infect. Immun. 63 1995 736-740
10. M.I. Voskuil et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program J. Exp. Med. 198 2003 705-713
11. R.M. McCune Jr. and R. Tompsett Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy J. Exp. Med. 104 1956 737-762
12. R.M. McCune Jr. et al. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug J. Exp. Med. 104 1956 763-802
13. R.M. McCune et al. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues J. Exp. Med. 123 1966 445-468
14. C.A. Scanga et al. Reactivation of latent tuberculosis: Variations on the Cornell murine model Infect. Immun. 67 1999 4531-4538
15. J.L. Flynn et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice Immunity 2 1995 561-572
16. T. Botha and B. Ryffel Reactivation of latent tuberculosis infection in TNF-deficient mice J. Immunol. 171 2003 3110-3118
17. H.M. Algood et al. TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection J. Immunol. 172 2004 6846-6857
18. J. Keane et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N. Engl. J. Med. 345 2001 1098-1104
19. M. Denis Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates Cell Immunol. 132 1991 150-157
20. J.L. Flynn et al. Effects of aminoguanidine on latent murine tuberculosis J. Immunol. 160 1998 1796-1803
21. J. Turner et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice J. Immunol. 169 2002 6343-6351
22. C.A. Scanga et al. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2 J. Exp. Med. 192 2000 347-358
23. L.A. van Pinxteren et al. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells Eur. J. Immunol. 30 2000 3689-3698
24. S.V. Capuano 3rd et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection Infect. Immun. 71 2003 5831-5844
25. J.E. Wigginton and D. Kirschner A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis J. Immunol. 166 2001 1951-1967
26. S. Marino and D.E. Kirschner The human immune response to Mycobacterium tuberculosis in lung and lymph node J. Theor. Biol. 227 2004 463-486
27. J.L. Segovia-Juarez et al. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model J. Theor. Biol. 231 2004 357-376
28. Flynn J. et al. Overcoming math anxiety: Malthus meets Koch. Am. Soc. Microbiol. News (in press)
29. D. Kirschner Dynamics of co-infection with M. Tuberculosis and HIV-1 Theor. Popul. Biol. 55 1999 94-109
30. S. Bajaria et al. Predicting differential responses to structured treatment interruptions during HAART Bull. Mathemat. Biol. 66 2004 1093-1118